Miguel Waterhouse

Hugstetter Str. 55
Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 25, 2026

Peri-transplant ruxolitinib prophylaxis improves outcome in patients receiving allogeneic hematopoietic cell transplantation for myelofibrosis.

Peri-transplant ruxolitinib prophylaxis improves outcome in patients receiving allogeneic hematopoietic cell transplantation for myelofibrosis.

Journal: Transplantation and cellular therapy

Published: May 08, 2026

Peri-Transplant Ruxolitinib Prophylaxis Improves Outcome in Patients Receiving Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis.

Peri-Transplant Ruxolitinib Prophylaxis Improves Outcome in Patients Receiving Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis.

Journal: Transplantation and cellular therapy

Published: May 08, 2026

Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donors.

Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donors.

Journal: Transfusion

Published: March 17, 2026

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.

Journal: Annals of hematology

Published: December 13, 2025

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: September 19, 2025

Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study.

Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study.

Journal: Bone marrow transplantation

Published: May 07, 2025

Identification of epigenetic modifiers essential for growth and survival of AML1/ETO-positive leukemia.

Identification of epigenetic modifiers essential for growth and survival of AML1/ETO-positive leukemia.

Journal: International journal of cancer

Published: October 08, 2023

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia.

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia.

Journal: Cancers

Published: July 14, 2023

Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation.

Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation.

Journal: Cancers

Published: May 07, 2022

Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.

Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.

Journal: International journal of molecular sciences

Published: September 16, 2021

Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.

Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.

Journal: Bone marrow transplantation

Published: August 20, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026